HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nikolai Pfender Selected Research

Daclizumab (Zenapax)

12/2014Daclizumab (anti-CD25) in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nikolai Pfender Research Topics

Disease

2Spinal Cord Injuries (Spinal Cord Injury)
01/2023 - 01/2020
2Multiple Sclerosis
12/2014 - 06/2013
2Hypersensitivity (Allergy)
01/2012 - 01/2011
1Demyelinating Diseases (Demyelinating Disease)
05/2024
1Atrophy
05/2024
1Spinal Cord Compression
01/2023
1Spinal Cord Diseases
01/2020
1Herpes Simplex Encephalitis (Herpes Encephalitis)
06/2015
1Inflammation (Inflammations)
12/2014
1Relapsing-Remitting Multiple Sclerosis
06/2013
1Allergic Contact Dermatitis
09/2012
1Contact Dermatitis (Eczema, Contact)
09/2012

Drug/Important Bio-Agent (IBA)

2AllergensIBA
09/2012 - 01/2012
1IronIBA
05/2024
1salicylhydroxamic acid (SHAM)IBA
01/2020
1Fingolimod Hydrochloride (FTY720)FDA Link
06/2015
1Daclizumab (Zenapax)FDA Link
12/2014
1HaptensIBA
09/2012
1Immunoglobulin E (IgE)IBA
01/2011
1Arthropod VenomsIBA
01/2011

Therapy/Procedure

1Decompression
01/2023
1Surgical Decompression
01/2020
1Injections
06/2013
1Hematopoietic Stem Cell Transplantation
06/2013